由OGT介导的O-GlcNAcylation通过向IRF1来调节心力衰竭中的巨细胞两极分化
1Department of Cardiovascular Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, 010050, China.
BMC cardiovascular disorders
|December 30, 2024
概括
沉默与O相关的N-乙糖胺 (O-GlcNAcylation) 酶OGT将巨细胞转移到抗炎状态,缓解心力衰竭 (HF). 这表明O-GlcNAcylation是高频率的潜在治疗标.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
背景情况:
- 心力衰竭 (HF) 是一个全球性健康问题,死亡率高.
- 巨细胞炎症对HF病变产生有显著的贡献.
- O-GlcNAcylation是一种后翻译性修饰,影响各种细胞过程.
研究的目的:
- 调查O-GlcNAcylation在心力衰竭中的作用.
- 确定O-GlcNAcylation对高频的巨细胞极化的影响.
主要方法:
- 利用脂聚糖 (LPS) 诱导Raw264.7细胞中的亲炎性巨细胞.
- 通过横向大动脉收缩 (TAC) 生成高频小鼠模型.
- 评估了使用qPCR和流细胞计在OGT淘汰或IRF1过度表达后的巨细胞极化;通过生物信息学,co-IP,IP和西部涂抹分析了机制.
主要成果:
- 在LPS治疗的细胞中观察到高的O-GlcNAcylation和OGT水平.
- 消灭OGT抑制了促炎性并促进了抗炎性巨细胞两极分化.
- 通过抑制IRF1 O-GlcNAcylation在Ser283.3,OGT沉默缓解了TAC诱导的心脏功能障碍和纤维化.
结论:
- OGT沉默促进了巨细胞两极分化向抗炎性表型的转变,从而改善了HF.
- 这种有益的效果是通过IRF1.1的O-GlcNAcylation进行介导的.
- O-GlcNAcylation成为心力衰竭治疗的有前途的治疗策略.
更多相关视频
07:45Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis
Published on: November 28, 2015
35.2K
07:46Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
25.1K
相关概念视频
Inflammation
50.8K
Overview
50.8K
Regulation of the Unfolded Protein Response
2.3K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.3K
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
